Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes

Virology

Volumn 231, Issue 2, 1997, Pages 290-300

  Zeller, J C ^a   Nguyen, N ^b   Southern, P J ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS NUCLEOCAPSID; VIRUS TRANSCRIPTION;

EID: 0031009038     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8507     Document Type: Article

References (50)

1. Allan J. E., Dixon J. E., Doherty P. C. Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr. Topics Microbiol. Immunol. 134:1987;131-143.
2. Aichele P., Kyburz D., Ohashi P. S., Odermatt B., Zinkernagel R. M., Hengartner H., Pircher H. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 91:1994;444-448.
3. Asano M. S., Ahmed R. Immune conflicts in lymphocytic choriomeningitis virus. Springer Semin. Immunopathol. 17:1995;247-259.
4. Bachmann M. F., Kundig T. M. In vivoin vitro. Curr. Opin. Immunol. 6:1994;320-326.
5. Battegay M., Oehen S., Schulz M., Hengartner H., Zinkernagel R. M. Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology. J. Virol. 66:1992;1199-1201.
6. Butz E. A., Southern P. J. Lymphocytic choriomeningitis virus induced immune dysfunction: Induction of and recovery from T-cell anergy in acutely infected mice. J. Virol. 68:1994;8477-8480.
7. Byrne J., Oldstone M. B. A. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:1984;682-686.
8. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
9. Cole G. A., Nathanson N., Prendergast R. A. Requirement for θ bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature. 238:1972;335-337.
10. Colle J-H., Saron M-F., Truffa-Bachi P. Altered cytokine genes expression by ConA-activated spleen cells from mice infected by lymphocytic choriomeningitis virus. Immunol. Lett. 35:1993;247-254.
11. Dutko F. J., Oldstone M. B. A. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1983;1689-1698.
12. Finkelman F. D., Lees A., Birnbaum R., Gause W. C., Morris S. C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1996;1406-1414.
13. b. J. Virol. 69:1995;2297-2305.
14. Glanville N., Durnam D. M., Palmiter R. D. Structure of the mouse metallothionein-I gene and its mRNA. Nature. 292:1981;267-269.
15. Hanahan D. Transgenic mice as probes into complex systems. Science. 246:1989;1265-1275.
16. Hogan B. L. M., Constantini F., Lacy E. Manipulation of the Mouse Embryo: A Laboratory Manual. 1986;Cold Spring Harbor Laboratory, New York.
17. Hotchin J. The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27:1962;479-499.
18. Jacobs R. P., Cole G. A. Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. J. Immunol. 117:1976;1004-1009.
19. Klavinskis L. S., Whitton J. L., Joly E., Oldstone M. B. A. Vaccination and protection from a lethal viral infection: Identification, incorporation and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology. 178:1990;393-400.
20. Kundig T. M., Bachmann M. F., DiPaolo C., Simard J. J. L., Battegay M., Lother H., Gessner A., Kuhlcke K., Ohashi P. S., Hengartner H., Zinkernagel R. M. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 268:1995;1343-1347.
21. Lee M. S., von Herrath M., Reiser H., Oldstone M. B. A., Sarvetnick N. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J. Clin. Invest. 95:1995;486-492.
22. Marker O., Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1973;1511-1525.
23. +. J. Immunol. 149:1992;1326-1333.
24. Mims C. A., Wainwright S. The immunosuppressive action of lymphocytic choriomeningitis virus in mice. J. Immunol. 101:1968;717-724.
25. Mondino A., Khoruts A., Jenkins M. K. The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA. 93:1996;2245-2252.
26. +. J. Virol. 61:1987;1867-1874.
27. Oehen S. U., Ohashi P. S., Burki K., Hengartner H., Zinkernagel R. M., Aichele P. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell. Immunol. 158:1994;342-352.
28. Ohashi P. S., Oehen S., Aichele P., Pircher H., Odermatt B., Herrera P., Higuchi Y., Buerki K., Hengartner H., Zinkernagel R. M. Induction of diabetes is influenced by the infectious virus and local expression of MHC classI and tumor necrosis factor-α J. Immunol. 150:1993;5185-5194.
29. Ohashi P. S., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
30. Oldstone M. B. A., Blount P., Southern P. J., Lampert P. W. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:1986;239-243.
31. Oldstone M. B. A., Dixon F. J. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J. Exp. Med. 129:1969;483-505.
32. Oldstone M. B. A., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell. 65:1991;319-331.
33. Oldstone M. B. A., Southern P. J. Trafficking of activated cytotoxic T lymphocytes into the central nervous system: Use of a transgenic model. J. Neuroimmunol. 46:1993;25-32.
34. Oldstone M. B. A., Whitton J. L., Lewicki H., Tishon A. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J. Exp. Med. 168:1988;559-570.
35. Palmiter R. D., Chen H. Y., Brinster R. L. Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell. 29:1982;701-710.
36. Razvi E. S., Welsh R. M. Programmed cell death of T lymphocytes during acute viral infection: A mechanism for virus-induced immune deficiency. J. Virol. 67:1993;5754-5765.
37. Rowe W. P. Studies on pathogenesis and immunity in lymphocytic choriomeningitis infection of the mouse. Res. Rept. Naval Med. Res. Inst. 12:1954;167-220.
38. Salvato M. S. The Arenaviridae. 1993;Plenum Press, New York.
39. Saron M. F., Shidani B., Nahori M. A., Guillon J. C., Truffa-Bachi P. Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes. J. Virol. 64:1990;4076-4083.
40. Schulz M., Aichele P., Vollenweider M., Bobe F. W., Cardinaux F., Hengartner H., Zinkernagel R. M. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1989;1657-1667.
41. Southern P. J. Arenaviridae: Virology. 1996;Lippincott-Raven, Philadelphia. p. 1505-1519.
42. Southern P. J., Singh M. K., Riviere Y., Jacoby D. R., Buchmeier M. J., Oldstone M. B. A. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology. 157:1987;145-155.
43. von Herrath M. G., Dockter J., Nerenberg M., Gairin J. E., Oldstone M. B. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180:1994;1901-1910.
44. Webb S., Morris C., Sprent J. Extrathymic tolerance to mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1990;1249-1256.
45. Whitton J. L., Gebhard J. R., Lewicki H., Tishon A., Oldstone M. B. A. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 62:1988a;687-695.
46. Whitton J. L., Sheng N., Oldstone M. B. A., McKee T. A. A "string of beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:1993;348-352.
47. Whitton J. L., Southern P. J., Oldstone M. B. A. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 162:1988b;321-327.
48. Whitton J. L., Tishon A., Lewicki H., Gebhard J., Cook T., Salvato M., Joly E., Oldstone M. B. A. Molecular analysis of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:1989;4303-4310.
49. Yokoyama M., Zhang J., Whitton J. L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684-2688.
50. Zarozinski C. C., Fynan E. F., Selin L. K., Robinson H. L., Welsh R. M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010-4017.